Kimberly-Clark Corp

KMB has decisively broken below the $103.16–$102.83 support zone on high volume, confirming a Stage 4 distribution and continued downtrend. Price sits below all EMAs amid oversold RSI, but short-term extension discourages immediate selling. Optimal execution is deferred: look to scale into weakness on relief rallies into the $102–$105 resistance band (including the 20 EMA) and seek rejection before selling.

• ↑Q2 revenue $4.19 B (+0.6% YoY) and adjusted EPS $1.80 (+10.4% YoY).
• ↑Gross productivity up 6.4% expanded gross margin by 190 bps to 38.8%.
• ↓Q2 net margin fell to 10.2% from 12.4%, hurting profits.